does semaglutide cause heart problems The weight-loss drug Wegovy lowered attack risk in a large trial National Consensus on Semaglutide in
Description
For most people, this difference is clinically insignificant during the first four weeks of titration
The name change capitalizes on the brand-name recognition of Ozempic , which has been available for subcutaneous administration in patients with type 2 diabetes since 2017
At 0.25 mg, you are not yet at a dose that produces significant weight loss or glycemic control
That is the honest read of the 2025 tirzepatide vs semaglutide evidence, and it is why EASO 2025 guidelines treat both drugs as first-line with tirzepatide favored for obesity without CV disease
